CRVS NASDAQ
Corvus Pharmaceuticals, Inc.
1W: -4.2%
1M: -26.7%
3M: -21.1%
YTD: +78.7%
1Y: +255.4%
3Y: +451.9%
5Y: +423.2%
$12.61
-0.47 (-3.59%)
Weekly Expected Move ±13.8%
$9
$11
$12
$14
$16
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-44M
Net Income
-6.7% YoY
$-35M
Free Cash Flow
-23.0% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-94.2%
ROA-63.1%
ROIC-702.2%
Valuation
P/E-25.7
P/B4.7
EV/EBITDA-26.6
Leverage
Debt/Equity0.02
Current Ratio6.21
Interest Cov.-26.6x
Quality Scores
Piotroski F3/9
Altman Z70.19
Beneish M0.00